Xenon Pharmaceuticals XENE Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$383.17M-52.4% | -$345.91M-47.6% | -$306.33M-43.6% | -$278.23M-39.8% | -$251.45M-33.3% | ||
| $2.47M-6.2% | $2.54M-0.7% | $2.6M— | $2.62M— | $2.63M— | ||
| $58.43M+9.2% | $53.71M+5.9% | $53.19M+14.9% | $52.49M+24.8% | $53.49M+49.5% | ||
| -$306.36M-55.6% | -$279.12M-53.9% | -$252.02M-55.2% | -$229.94M-43.0% | -$196.85M-20.9% | ||
| $889K-69.7% | $799K-74.0% | $1.26M-46.7% | $1.57M-47.2% | $2.93M-18.6% | ||
| -$223.79M-192% | $218M+32.1% | $253.8M+246% | $215.77M+280% | $242.7M+221% | ||
| $958.98M+7,121% | $117.11M+865% | $15.71M-95.2% | $13.35M— | $13.28M— | ||
| $429.21M— | $56.45M— | —— | —— | —— | ||
| -$307.25M-53.8% | -$279.92M-51.7% | -$253.29M-53.7% | -$231.51M-41.3% | -$199.78M-20.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Xenon Pharmaceuticals generate?
- Xenon Pharmaceuticals (XENE) generated -$306.4M in operating cash flow over the trailing twelve months.
- What is Xenon Pharmaceuticals's free cash flow?
- After $889.0K of capital expenditures, Xenon Pharmaceuticals's free cash flow was -$307.3M over the trailing twelve months, down 53.8% year over year.
- Where does Xenon Pharmaceuticals's cash flow data come from?
- Every line is extracted from Xenon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.